$ACMR

Wang David H sold $110K of ACMR

Wang David H (See Remarks) sold 1,187 shares of ACM Research, Inc. (ACMR) at $93.04 ($0.11M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ACMR
Neutral
medium confidence
Mentioned
$ACMR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRNeutralLow
01

Why it matters

The disclosure provides a data point on insider activity but does not, by itself, change the company’s fundamentals or forward outlook.

02

Market read

Expect minimal fundamental impact; any price effect is likely sentiment-driven and short-lived given 10b5-1 context.

03

What to watch

Traders may overreact to Form 4 volume; the key is whether there are repeated sales/buys around the same period or any concurrent fundamental catalysts.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed June 5 (sale executed June 3)

Background

This is a routine SEC Form 4 insider transaction for ACM Research, Inc. (ACMR), reported as an open-market sale under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$ACMRNeutralMedium confidence
Context

ACMR insider David H. Wang sold 1,187 shares in an open-market transaction disclosed via SEC Form 4 on June 3, 2026.

Expected impact

Likely limited/short-lived impact; any reaction should fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is an ownership-change disclosure (Form 4) with an explicit 10b5-1 plan, which reduces the likelihood of information asymmetry.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is pre-arranged under 10b5-1, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • ACM Research, Inc.

    Subject of the insider transaction disclosure (Form 4).

  • David H. Wang

    Officer/Director/10% owner who sold shares; transaction executed June 3, 2026.

Related articles

$ACMRMed

ACM Research, Inc. Q2 2026 Earnings Call Summary

ACM Research (ACM) reported Q2 2026 revenue up 36% YoY, driven by ECP and advanced packaging categories. The company said it received panel-level horizontal plating orders from two customers and expects full-year 2026 revenue guidance of $1.125B to $1.175B. It noted cleaning revenue fell 14% and net cash exceeds $1B.